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BODYMASS AND FLUID DISTRIBUTION DURING LONGTERM SPACEFLIGHT
WITH AND WITHOUT COUNTERMEASURES
K. A. Kirsch, F. Baartz, H.-Ch. Gunga, E. Koraleweski and B. Johannes
Dept. of Physiology, Free University Berlin, !4 i 95 Berlin, Arnimallee 22, Germany
INTRODUCTION
Exposure to micro-g is followed by a fluid shift from the lower limbs towards the upper part of the body and
simultaneously a fluid loss occurs. We therefore studied the dynamics of the fluid shift in relation to the fluid
loss during short and long term spaceflights. In the latter case countermeasrues were applied to prevent a fluid
mobilisation from the lower limbs.
METHODS
8 male subjects took part in the study during 5 different space missions. Two subjects were on the D-2
Mission, 6 were on the Mir-Station. In the short term flights (4 sujects) no countermeasures like cuffs around the
thighs were used. In the long term flights (33 - 436 days) countermeasures were applied. The tissues thickness
(TT) was measured in superficial tissues by ultrasound probes attached along the tibia and in the front. Pre-, In-
and postflight data were collected. During long term flights Body Mass (BM) was taken together with the TT
values.
RESULTS
During all missions facial tissue swellings appeared within the first hours but tended to diminish during the
flight. The shrinking of the limb tissues(-15%)wasmore outspoken than the tissue swellings in the front
(+ 7 %) and remained unchanged throughout the flight as observed during the short term missions. In the long
term flights the application of the cuffs prevented a fluid mobilisation from the lower limbs but not the swelling
of the facial tissues. In the front between the BM changes and the TT changes inflight always a strong
correlation existed (p< 0.01).
CONCLUSIONS
Swellings of the facial tissues during space flight are dependent from the water balance of the body, they can
not be prevented by countermeasures.
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PLASMA VOLUME, EXTRACELLULAR FLUID VOLUME, AND REGULATORY
HORMONES DURING LONG-TERM SPACE FLIGHT H.W. Lane, B.V. Morukov,
I.M. Larina, S.M. Smith, A.I. Grigoriev, C.S. Leach. NASA Johnson Space Center,
Houston, TX; Institute for Biomedical Problems, Moscow, Russia.
Exposure to microgravity causes headward fluid shifts, and it is hypothesized
that the body perceives this as an increased circulatory volume. Within hours of
entering microgravity, a 12-15% decrease in plasma volume (PV) and a 10%
decrease in extracellular fluid (ECF) occur. The PV decreases through a shift of
plasma out of the vascular compartment, initially to the extravascular ECF and then
to the intracellular compartment. The net result is a shift of fluid from the ECF to
the intracellular fluid compartment. Concurrently, erythropoiesis is downregulated
resulting in a 12-15% decrease in red blood cell mass, with an overall 12-15%
reduction in blood volume. These observations have been well characterized in
short-term space flight. We report here data from a 115-d mission aboard the Mir
space station.
Three male subjects participated in these studies (age 47 + 12 years, mean
+ SD; body weight 77.9 + 7.2 kg). Plasma volume was measured before flight
and on landing day using the carbon monoxide rebreathing technique. Extracellular
fluid volume was determined before and during flight using the bromide dilution
technique. Blood and urine samples were collected, aliquoted, and frozen until
postflight analysis, except for blood sodium and potassium, which were determined
in "real-time" with a portable clinical blood analyzer. Plasma levels of aldosterone,
antidiuretic hormone (ADH), and atrial natriuretic peptide (ANP) were determined
before flight and after 110 d of flight. Results are shown below; all data are mean
+ SD.
Anolvte
Plasma Volume (L)
Extracellular Fluid Volume (L)
Aldosterone (pg/ml)
ADH (pg/ml)
ANP (pg/ml)
• Landing day data
Preflight Inflight
3.16±0.15 3.01 ±0.08'
19.53±2.16 15.56± 1.80
109 ± 34 73 ± 29
2.6±1.3 0.9+0.4
20.0+ 12.7 12.6+ 11.6
The decreases in plasma volume and extracellular fluid volume are similar to
changes found in 14-d Shuttle flights. After 1 10 days of flight, plasma ADH
concentrations of all crewmembers and ANP of 2 of the 3 had decreased compared
to preflight values. The initial changes in fluid volumes that occur during space
flight appear to remain throughout long-term flight. This indicates that these are
not transient effects, but rather reflect an adaptation to space flight which occurs
within the first days to weeks of flight.
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EFFECT OF MICROGRAVITY AND ITS GROUND-BASED MODELS ON FLUID
VOLUMES AND HEMOCIRCULATORY VOLUMES
V.I. Lobachik, V.V. Polyakov, S.A. Chupushtanov, S.F. Voronov
State Scientific Center Rim Institute of Biomedical Problems, Moscow, Russia
INTRODUCTION
Despite certain achievements of space exploration, many important problems of space medicine remain
unresolved. There is no clear scientifically validated concept of the pathogenesis of the effect of space flight
(SF) factors upon the human body; its most vulnerable functions and systems have not been identified; the
compensatory reserve of the body remains undetermined. All this prevents further increase of space flight
duration, prediction of the development of sub-pathological states as well as further optimisation of
countermeasures and purposeful correction of the status of body functions. Among the unresolved problems of
space medicine, the leading one are, in our view: the change, during SF, of the functioning of the circulatory
system (CS) manifested as a decreased orthostatic tolerance of cosmonauts; disturbed cardiac rhythm, increased
blood filling of parenchimatous organs during SF, the space anaemia syndrome; decreased content of fluids and
hemocirculatory volumes. The subject of discussion in this work is a study of fluid and blood volumes. It is
obvious that these studies require a complex approach and the use of modem measuring techniques. The most
adequate are, in our view are stable and/or radioactive isotopes. Great experience has been accumulated of
complex studies of fluid and blood volumes in various ground-based simulation experiments using a complex of
stable and radioactive isotopes. However, scanty and fragmentary data obtained during space flight have not
allowed to determine the identical nature of physiological effects seen during simulation experiments and SF.
This could be resolved only by quantitative measurements of blood and fluid volumes directly during SF. After
developing methods for delivery, means for investigation, and ways of returning the biomaterials to the Earth,
these measurements were performed aboard the "Mir" orbital station during orbital missions (OM) 15--17 in 2
cosmonauts: the physician (OM 15--17) and commander of OM-16. The in-flight studies were performed by
physician-cosmonaut.
METHODS
The following radioisotopes were used: tritium water and labelled albumin (J-131), as well as stable
bromide. The following volumes were studied: total body water (TBW), intracellular water space (ICWS),
extracellular fluid (ECF), and its fractions: plasma (PV) and the intersticial fluid (IFV), as well as blood and
erythrocyte volumes (BV and EV). Studies were performed pre-flight, on flight days 4-5 (in physician and
commander) and on day 434 (in physician) as well as during readaptation.
RESULTS
On days 4 and 5 of SF in physician and commander the TBW was lower than pre-flight by 4 and 5 %
respectively. The ECF was lower than pre-flight by 9 and 10 % respectively. The ICWS within the SF duration
was unchanged. BV in commander was lower than pre-flight by 8 % due to his own plasma. The erythrocyte
mass volume was not decreased. Observation of physician on the SF day 434 revealed a decrease of ECF by 18
% as related to pre-flight. This was due both to plasma and to the interstitial fraction which changed more
signi_cantly. I_atios of fluid fractions changed insignificantly. The post-flight observation of commander on day
1 aft& completing his 158-day SF, revealed a decreased content of all fluids: TBW by 10 %, ECF by 23 %,
ICWS by 5 % as related to the pre-flight value. The post-flight observation of physician on day 14 after landing
demonstrated that the changes noted at the end of SF by the day of readaptation mentioned were slight.
However, the changed ratio of the vascular and interstitial fractions was maintained. The work presents a
comparative analysis of changes in hydrational homeostasis and hemocirculatory volume during microgravity
and ground-based simulation experiments -- clynostatic hypokinesia, head-down hypokinesia with a tilt angle
of 5 and 15 °, vertical immersion.
CONCLUSIONS
Due to the inadequate number of observations during SF, the conclusions are preliminary. On days 4 and 5
of adaptation to SF, a new level was formed of hydrational homeostasis and hemocirculatory volumes at a lower
quantitative level most marked was the decrease of the extracelhilar fluid volume and its fractions, The
intracellular fluid volume was unchanged, which disturbed their ratios. During a prolonged space flight in
phisician, the changes progressed. The most marked were also changes in the extracellular water space, mainly
due to the interstitial fraction. During readaptation for 14 days, the changes noted in-flight, practically returned
to pre-flight values. A comparative analysis of changes in fluid and blood volumes during microgravity and
ground-based simulation experiments demonstrated that, preliminary, they have a common direction of changes.
However, each of the above models has its peculiarities and differences.
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SEVENTEEN WEEKS OF HORIZONTAL BED REST, LOWER BODY NEGATIVE
PRESSURE TESTING, AND THE ASSOCIATED PLASMA VOLUME RESPONSE
Claire M. Lathers, Ban" Laboratories Inc., Pomona, NY
John B. Charles, NASA Johnson Space Center, Houston, Texas
INTRODUCTION
Both space flight and BR are associated with a cephalad shift of body fluids, diuresis, a decrease
in plasma volume (PV) and orthostatic intolerance. The loss of orthostatic tolerance can be
documented during bed rest (BR) using lower body negative pressure (LBNP).
METHODS
This study was conducted in Methodist Hospital, Baylor College of Medicine, as an adjunct
investigation to a primary study designed to document hypokinesia-induced Ca++ loss. We
examined PV in 4 healthy male subjects before, during, and after 17 weeks of horizontal BR.
LBNP was performed weekly to document orthostatic tolerance. The LBNP protocol consisted
ofa 10-min control period at ambient pressure; 5 rains each at 5, 10, and 20 mm Hg, but it
increased at 30, 40, and 50 mm Hg LBNP. Pre-BR, peak HR was 97+-10 bpm, occurring at 50
mm Hg. After 3 days of BR, all HR responses, including values after release of LBNP, were only
slightly elevated (ns) above pre-BR level. Peak HR was 118+-21 bpm at 50 mm Hg
decompression (ns). After 3 weeks of BR, peak HR was 110+-16 bpm at 50 mm Hg
decompression (ns). The slight increase (ns) in HR persisted throughout the 17 weeks ofBR. A
decrease in the duration of tolerance to LBNP occurred in 3 subjects. Mean PV was decreased
5% to 4% (sig different from almost all other days) on day 36 and 42 of BR, respectively. All
other PV values did not vary much, ranging from -1.5% to 1% of control.
CONCLUSIONS
The data indicate that the HR changes associated with orthostatic instability develop early, after
as few as 3 days of BR, and persist throughout the entire 17 weeks of horizontal BR. Sandier
(NASA 1988 Technical Memorandum 88314) summarized data from many BR studies and
reported that PV exhibited a rapid 8-10% loss over the first few days of BR. PV values were then
stabilized at -15 to 20% between 14 to 28 days and exhibited decreases up to 30% when the
duration of BR was from 100 to 200 days. Udden et al (Space Physiology and Medicine, Lea &
Febiger, p 350, 1994) reported a 23% decrease in PV after 24 hours of space flight; values 9 days
later, at landing, were only decreased by 10%. PV values returned to control six days after
landing. In the 17 week BR study the peak magnitude of the PV decrease, (-5%) detected on day
36 of BR, was one-half that reported after 9 days of space flight. On day 15 ofBR, PV values
were no different from those at day 0. In conclusion, the data show a decrease in PV like other
BR and space flight studies, but the magnitude of the decrease and the time frame in which the
decrease occurred were different. In general, PV was maintained during the 17 weeks of
horizontal BR. The data suggest that the slight decrease in PV did not, by itself, alter the HR
changes associated with the orthostatic stress induced by LBNP.
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EVAPORATIVE WATER.LOSS IN SPACE
THEORETICAL AND EXPERIMENTAL STUDIES.
F. Baartz, F. Castrucci, H.-Chr. Gunga, E. Koralewski and K. Kirsch
Dept.of Physiology, Free University Berlin, i 4195 Berlin, Arnimallee 22, Germany
INTRODUCTION
During space flight often water loss occurs in man but it is unknown whether a reduced intake or an increased
output is responsible for the fluid loss. In a theoretical study evaporative water loss (EVA) was estimated and
compared with results obtained during head down tilt (HDT) studies.
METHODS
In the theoretical study besides the usual climate factors prevailing in a space craft micro-g conditions were
assumed which would exclude thermal convection.
Experimental studies were performed in 12 male subjects measuring EVA in supine and HDT conditions. EVA
was measured with an evaporimeter (Servo-Med Sweden) in 8 points along body axis.
RESULTS
The theoretical study revealed an evaporative loss of 6.1 g m "2"h"t, which is a very low rate comapred to data
seen on ground.
Subjects with high (n = 4) and low (n = 6) EVA rates during rest in supine postion were seen.During HDT the
subjects with high resting EVA rates responded with significantly redurced EVA values (p<0.01). The
individual typ of subject seen in supine position determined the EVA rate rather than the HDT manoeuvre.
CONCLUSIONS
Theoretically low EVA rates in micro-g can be exspected. Simulated micro-g can affect EVA depending on
individual. Wether this plays a role under stress conditions like in space remains to be determined. Only direct
measurements in space can solve the problem.
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ERYTHROPOIETIN UNDER REAL AND SIMULATED MICRO-G CONDITIONS
IN HUMANS
H.-C. GUNGA 1, K. KIRSCH 1, A. MAILLET 2, F. BAARTZ 1, C. GHARIB 2, W. NALISHITI 3, I. RICH 4, L. R(SCKER 1
1) Department of Physiology, Free University of Bedin, Amimallee 22, D 14 195 Berlin, Germany; 2) Laboratoire de Physiologie de
I'Environment, Facult_ de M_decine Lyon Grange-Blanche, 8 Avenue Rockefeller, F-69373 Lyon, France; 3) ZPK, 14160 Star City,
Moscow, Russia; 4) German Red Cross, University UIm, HalrnholtzstraBe 10, 89081 UIm, Germany
INTRODUCTION
It was the aim of this study 1) to analyze the time course of erythropoietin during earth-bound
micro-g simulations such as bed-rest, isolation and confinement, head-down tilt (-6°), and immersion
so as to evaluate 2) which factors could contribute to alterations found in erythropoietin under real
micro-g conditions during and after short- (<10 days) and long-term (>6 months) space-flights.
METHODS
Serum and plasma samples were taken and analysed for erythropoietin by radioimmunoassay and
enzyme linked immunoassays before, during and after the following test settings: bed-rest (N=10,
male, 24 hrs); isolation and continent (N = 4; 1 female, 3 male, 8 weeks); head-down tilt (-6°) (N = 8,
male, 42 days); immersion (N = 8, male, 1 hr); short- (N = 4, male, 10 days) and long-term (N = 1,
male, 135 days) space-flight.
RESULTS
During bed-rest (24 hrs) no significant changes in erythropoietin could be observed. The subjects
confined in a diving chamber facility for 8 weeks showed, after 3 weeks inside the chamber, an
erythropoietin decrease until the last week inside the chamber. In the recovery period a slight
increase was observed, but erythropoietin concentrations did not reach the pre-isolation control level.
In the control period before head-down tilt (-6 °) the subjects showed normal resting values for
erythropoietin, but already on the 2nd day of head-down tilt the erythropoietin concentrations were
decreased (P<0.01). During the following weeks the erythropoietin levels remained below the control
value and were increased during the 1st week post-head-down tilt (P<0.05). After immersion (1 hr) the
erythropoietin values were unchanged, whereas 24 hrs later a significant increase could be
determined (P<0.05). During the German D-2 mission, a short-term space-flight (10 days), the
astronauts showed pre-flight normal resting erythropoietin levels (9.3 + 2.2 mU. ml-1). In-flight (4th
day) the erythropoietin concentrations were decreased (6.0 + 5.1 mU. ml-1): two astronauts had very
low erythropoietin levels (subject A 0.3 mU . ml-1; subject D 3.3 mU . ml-1) while the other ones
showed nearly unchanged concentrations. On the recovery day the erythropoietin concentrations were
slightly further decreased (5.6 + 3.3 mU. ml-1) and increased slowly towards control level in-th e post-
flight phase (7th day 7.4 + 3.4 mU. ml-1; 15th day 10.9 + 2.1 mU. ml-1). During the EUROMIR'94-E
mission, a long-term space-flight (135 days), the cosmonaut showed pre-flight normal resting
erythropoietin levels (14.4 mU . ml-1). One day after the recovery the erythropoietin concentration
was slightly elevated, but in the normal range (19.4 mU. ml-1). In the following post-flight phase the
erythropoietin values increased markedly (2nd day 46.3 mU . ml-1) and remained elevated (5th day
43.1 mU. ml-1).
CONCLUSION
It is concluded that 1) head-down tilt (-6 °) causes a rapid erythropoietin decrease in man; 2)
isolation and confinement per se lead to diminished erythropoietin concentrations; 3) during a short-
duration spaceflight (<10 days) extremely low erythropoietin concentrations were observed in-flight in
two out of four astronauts, whereas in the other ones unchanged erythropoietin concentrations were
determined. After two weeks post-flight all subjects showed normal erythropoietin concentration; 4)
increased erythropoietin concentrations above control range were found immediately after long-term
space flights; 5) changes in central blood volume, i.e. central venous pressure, might be involved in
the modulation of erythropoietin production and release under simulated and real micro-g conditions;
and 6) the head-down tilt (-6 °) earth-bound simulation reflects most likely the changes in
erythropoietin production and release observed under micro-g conditions in man.
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VERTEBRAL BONE MARROW CHANGES FOLLOWING SPACE FLIGHT
A. LeBlanc 1, C. Lin 1, H. Evans 2, L. Shackelford 3, S.West _, T. Hedricks _
1Baylor College of Medicine, 2Krug life sciences, 3Johnson space Center, Houston Tx.
INTRODUCTION
It is known from bone biopsies that marrow fat increases 100% during the first 20 weeks of paralysis. The
exact function of marrow adipose cells and their relation to bone metabolism and hematopoiesis is unknown,
however, it is known that bone marrow adipose ceils have a reciprocal relationship to hematopoietic tissue. As
the hematopoietic tissue expands the lipid fraction of the adipose cells decreases while the opposite occurs during
decreases in hematopoiesis. A number of studies suggest linkage between the bone marrow microenvironment
and osteoblastic activity. With magnetic resonance spectroscopy (MRS), the possibility exists to examine these
changes in vivo. One objective of our Life and Microgravity Spacelab (LMS) experiment, flown in July of
1996, was to document this expected change in the marrow composition using a noninvasive MRS technique
developed in our laboratory.
METHODS
LMS was a 17 day Spacelab mission dedicated to life and microgravity research. The 4 payload
crewmembers participated in the magnetic resonance experiment which involved MRS scanning at L-60, L-30,
R+2, R+14 and R+30 days. To measure the fat to water ratio in vertebral bone marrow, volume selective
proton spectra were obtained using a surface receive coil. A cubic volume of interest of 15ram x 15mm x
15ram located in the center the L3 vertebral body was selected based on the initial scan of the spine region. A
Gradient Inversion Spectroscopy technique was used to acquire spectra at TE = 12, 18, 24, and 30 ms with TR =
2s. The images were corrected for T2 weighting by exponential extrapolation of the spectra obtained at various
TE. The intensities of fat and water were calculated by integrating the areas under the fat and water peaks after
baseline correction. Bone marrow cellularity was determined from the fat to water ratio.
RESULTS
Immediately post-flight no significant change in the fraction of the water (cellular) component was found
although subsequent post-flight measurements may indicate some change. There appeared to be a small decrease
in the T2 of the cellular component post-flight, but what was surprising was the increase in T2 in all
crewmembers that was clearly evident by the final data collection point at 30 days post-flight. We obtained IRB
and astronaut permission to obtain additional measurements when the crewmember's time and schedule
permitted. The data collected to date are shown in figure 1. For 3 of the 4 crewmembers, the T2 remains
elevated above baseline 130 days after landing. There was no change in the T2 of the fat component. The T2
of the fat and water components for three volunteers measured over a one year interval overlapping the time
when the flight data was collected showed no significant change.
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DISCUSSION
Since the fraction of the cellular portion of the marrow is changing only slightly if at all, ianplies that the
observed T2 change in the cellular component represents a change in the cellular composition of the marrow.
One explanation is increased hematopoiesis to replace lost red cells following flight since the loss of red cell
mass during short duration weightlessness is documented. However, the time frame of the T2 response is much
longer than needed to replace lost red ceils which should be completed in about one month after flight. Another
explanation for the post-flight T2 response might be increased osteoblastic activity which might be expected to
have a longer time frame. Our 17 week bed rest studies demonstrated an increase in bone formation markers
compared to pre-bed rest after reambulation; alkaline phosphatase by 50% and osteocalcin by 33%.
CONCLUSION
There are significant T2 changes in the vertebral bone marrow observed with MRS after short duration flight
(17 days). These changes demonstrate a time course lasting several months suggesting accelerated osteoblastic
activity after return to earth's gravity. These findings have significant implications for medical research on earth
as well as microgravity.
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